Global Constipation Treatment Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Constipation Treatment Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Constipation Treatment Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Constipation Treatment Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Retail Pharmacies and Hospital Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Constipation Treatment Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Constipation Treatment Drug key manufacturers include AstraZeneca, Bayer AG, Sanofi, Sucampo Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited, Ironwood Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, Inc. and Abbott Laboratories, etc. AstraZeneca, Bayer AG, Sanofi are top 3 players and held % sales share in total in 2022.
Constipation Treatment Drug can be divided into Laxatives, Chloride Channel Activators, 5-HT4 Receptor Agonists and GC-C Agonists, etc. Laxatives is the mainstream product in the market, accounting for % sales share globally in 2022.
Constipation Treatment Drug is widely used in various fields, such as Retail Pharmacies, Hospital Pharmacies and Online Pharmacies,, etc. Retail Pharmacies provides greatest supports to the Constipation Treatment Drug industry development. In 2022, global % sales of Constipation Treatment Drug went into Retail Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Constipation Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Bayer AG
Sanofi
Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceuticals Company Limited
Ironwood Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc.
Abbott Laboratories
Cosmo Pharmaceuticals NV
Synergy Pharmaceuticals, Inc.
Prestige Brands Holdings, Inc.
Janssen Pharmaceutical Company
Shionogi & Co., Ltd.
Renexxion, LLC
Daewoong Pharmaceuticals Co. Ltd.
Albireo Pharma, Inc.
Segment by Type
Laxatives
Chloride Channel Activators
5-HT4 Receptor Agonists
GC-C Agonists
Peripherally Acting Mu-Opioid Receptor Antagonists
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Constipation Treatment Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Constipation Treatment Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Constipation Treatment Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Constipation Treatment Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Constipation Treatment Drug introduction, etc. Constipation Treatment Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Constipation Treatment Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Constipation Treatment Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Constipation Treatment Drug key manufacturers include AstraZeneca, Bayer AG, Sanofi, Sucampo Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited, Ironwood Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, Inc. and Abbott Laboratories, etc. AstraZeneca, Bayer AG, Sanofi are top 3 players and held % sales share in total in 2022.
Constipation Treatment Drug can be divided into Laxatives, Chloride Channel Activators, 5-HT4 Receptor Agonists and GC-C Agonists, etc. Laxatives is the mainstream product in the market, accounting for % sales share globally in 2022.
Constipation Treatment Drug is widely used in various fields, such as Retail Pharmacies, Hospital Pharmacies and Online Pharmacies,, etc. Retail Pharmacies provides greatest supports to the Constipation Treatment Drug industry development. In 2022, global % sales of Constipation Treatment Drug went into Retail Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Constipation Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Bayer AG
Sanofi
Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceuticals Company Limited
Ironwood Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc.
Abbott Laboratories
Cosmo Pharmaceuticals NV
Synergy Pharmaceuticals, Inc.
Prestige Brands Holdings, Inc.
Janssen Pharmaceutical Company
Shionogi & Co., Ltd.
Renexxion, LLC
Daewoong Pharmaceuticals Co. Ltd.
Albireo Pharma, Inc.
Segment by Type
Laxatives
Chloride Channel Activators
5-HT4 Receptor Agonists
GC-C Agonists
Peripherally Acting Mu-Opioid Receptor Antagonists
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Constipation Treatment Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Constipation Treatment Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Constipation Treatment Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Constipation Treatment Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Constipation Treatment Drug introduction, etc. Constipation Treatment Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Constipation Treatment Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.